Wambolt & Associates LLC trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 10.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,358 shares of the company’s stock after selling 154 shares during the quarter. Wambolt & Associates LLC’s […] Read this story
